ChemPartner Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2,076

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

  • Investments
  • 4

ChemPartner General Information

Description

Operator of a research organization intended to offer high-quality and cost-effective services to the biopharmaceutical industry. The company offers a broad range of integrated services across the drug discovery and development process, enabling it to serve the pharmaceutical and biotechnology companies around the globe.

Contact Information

Formerly Known As
ShangPharma
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 1F & 3F, Block A, 2829 JinKe Road
  • Zhangjiang Hi-Tech Park, PuDong New Area
  • Shanghai, 201203
  • China
+86
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 1F & 3F, Block A, 2829 JinKe Road
  • Zhangjiang Hi-Tech Park, PuDong New Area
  • Shanghai, 201203
  • China
+86

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ChemPartner Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ChemPartner‘s full profile, request access.

Request a free trial

ChemPartner Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a research organization intended to offer high-quality and cost-effective services to the biopharmaceutical
Drug Discovery
Shanghai, China
2,076 As of 2011

Shanghai, China
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ChemPartner Competitors (55)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Shanghai Medicilon Formerly VC-backed Shanghai, China
KBI BioPharma Formerly VC-backed Durham, NC
Dalton Pharma Services Corporate Backed or Acquired Toronto, Canada
Syngene International Formerly PE-Backed Bangalore, India
Pharmaron Formerly VC-backed Beijing, China
You’re viewing 5 of 55 competitors. Get the full list »

ChemPartner Patents

ChemPartner Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3164325-A1 Alpha-5 beta-1 inhibitors Pending 10-Dec-2019
US-20210171455-A1 Alpha-5 beta-1 inhibitors Active 10-Dec-2019
AU-2020401188-A1 Alpha-5 beta-1 inhibitors Pending 10-Dec-2019
US-11530180-B2 Alpha-5 beta-1 inhibitors Active 10-Dec-2019
EP-4072541-A1 Alpha-5 beta-1 inhibitors Pending 10-Dec-2019 C07C279/18
To view ChemPartner’s complete patent history, request access »

ChemPartner Executive Team (7)

Name Title Board Seat
Xianwei Zeng Chairman & Chief Executive Officer
Michael Hui Chief Executive Officer
Walter Moos Ph.D Chief Executive Officer, ShangPharma Innovation
You’re viewing 3 of 7 executive team members. Get the full list »

ChemPartner Board Members (2)

Name Representing Role Since
ChemPartner Chairman & Chief Executive Officer
You’re viewing 1 of 2 board members. Get the full list »

ChemPartner Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ChemPartner Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ChemPartner‘s full profile, request access.

Request a free trial

ChemPartner Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Circle Pharma 02-Dec-2018 Drug Discovery
Circle Pharma 25-Apr-2017 Drug Discovery
Morphic Therapeutic 30-Jun-2016 Drug Discovery
Morphic Therapeutic 01-Jun-2015 Seed Round Drug Discovery
To view ChemPartner’s complete investments history, request access »

ChemPartner FAQs

  • When was ChemPartner founded?

    ChemPartner was founded in 2002.

  • Who is the CEO of ChemPartner?

    Xianwei Zeng, Michael Hui, and Walter Moos Ph.D are the CEOs of ChemPartner.

  • Where is ChemPartner headquartered?

    ChemPartner is headquartered in Shanghai, China.

  • What is the size of ChemPartner?

    ChemPartner has 2,076 total employees.

  • What industry is ChemPartner in?

    ChemPartner’s primary industry is Drug Discovery.

  • Is ChemPartner a private or public company?

    ChemPartner is a Private company.

  • What is the current valuation of ChemPartner?

    The current valuation of ChemPartner is .

  • What is ChemPartner’s current revenue?

    The current revenue for ChemPartner is .

  • How much funding has ChemPartner raised over time?

    ChemPartner has raised $122M.

  • Who are ChemPartner’s investors?

    TPG has invested in ChemPartner.

  • Who are ChemPartner’s competitors?

    Shanghai Medicilon, KBI BioPharma, Dalton Pharma Services, Syngene International, and Pharmaron are some of the 55 competitors of ChemPartner.

  • When was ChemPartner acquired?

    ChemPartner was acquired on 16-Aug-2018.

  • Who acquired ChemPartner?

    ChemPartner was acquired by Quantum Hi-Tech (China) Biological Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »